Inventor · disambiguated record
Surjit Bhimarao Dixit
Also filed as: DIXIT SURJIT · DIXIT SURJIT B · DIXIT SURJIT BHIMARAO
32 granted patents·28 pending applications·352 citations·filing 2009–2025
97Inventor score
Files withZYMEWORKS INC39ZYMEWORKS BC INC15REVERB THERAPEUTICS INC2D ANGELO IGOR1DIXIT SURJIT BHIMARAO1
Top patents by PatentIndex Score
60 records- 0197US9499634B2Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cellsZYMEWORKS INC·Filed 2013·Granted Nov 22, 2016·50 cites·30 claims
- 0296US10000576B1Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2018·Granted Jun 19, 2018·23 cites·30 claims
- 0396US9574010B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2012·Granted Feb 21, 2017·48 cites·79 claims
- 0495US10457742B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2017·Granted Oct 29, 2019·17 cites·32 claims
- 0593US9562109B2Stable heterodimeric antibody design with mutations in the Fc domainVON KREUDENSTEIN THOMAS SPRETER·Filed 2011·Granted Feb 7, 2017·83 cites·30 claims
- 0692US9914785B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2013·Granted Mar 13, 2018·17 cites·15 claims
- 0791US11286293B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2018·Granted Mar 29, 2022·6 cites·25 claims
- 0891US9388231B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2013·Granted Jul 12, 2016·16 cites·38 claims
- 0990US11306156B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS INC·Filed 2015·Granted Apr 19, 2022·7 cites·37 claims
- 1090US11078296B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2018·Granted Aug 3, 2021·5 cites·12 claims
- 1190US10077298B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2013·Granted Sep 18, 2018·15 cites·22 claims
- 1290US9988460B2Crystal structures of heterodimeric Fc domainsZYMEWORKS INC·Filed 2017·Granted Jun 5, 2018·8 cites·15 claims
- 1390US2025122305A1Bispecific antigen binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 1489US11325981B2Bispecific antigen-binding constructs targeting Her2ZYMEWORKS INC·Filed 2018·Granted May 10, 2022·2 cites·19 claims
- 1589US10947319B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2014·Granted Mar 16, 2021·5 cites·18 claims
- 1689US10155803B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2016·Granted Dec 18, 2018·3 cites·27 claims
- 1789US9732155B2Crystal structures of heterodimeric Fc domainsZYMEWORKS INC·Filed 2013·Granted Aug 15, 2017·12 cites·15 claims
- 1888US10875931B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2017·Granted Dec 29, 2020·4 cites·8 claims
- 1988US9499605B2Multivalent heteromultimer scaffold design and constructsDIXIT SURJIT BHIMARAO·Filed 2012·Granted Nov 22, 2016·15 cites·24 claims
- 2085US2025197527A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 2184US2024343802A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 2281US12215166B2Bispecific antigen binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2022·Granted Feb 4, 2025·0 cites·23 claims
- 2381US10711051B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2018·Granted Jul 14, 2020·1 cites·21 claims
- 2481US9296815B2Antibodies with enhanced or suppressed effector functionD ANGELO IGOR·Filed 2011·Granted Mar 29, 2016·9 cites·14 claims
- 2580US11152081B2Methods for determining correlated residues in a protein or other biopolymer using molecular dynamicsZYMEWORKS INC·Filed 2016·Granted Oct 19, 2021·3 cites·7 claims
- 2678US10358479B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2016·Granted Jul 23, 2019·2 cites·24 claims
- 2776US11965036B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 2875US10508154B2Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cellsZYMEWORKS INC·Filed 2016·Granted Dec 17, 2019·1 cites·37 claims
- 2972US12304945B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS BC INC·Filed 2022·Granted May 20, 2025·0 cites·20 claims
- 3071US12286489B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2022·Granted Apr 29, 2025·0 cites·40 claims
- 3171US2021317212A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 3271US2024327815A1Multivalent polypeptide constructs capable of binding viral spike proteins and methods of using the sameZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 3369US12060436B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS BC INC·Filed 2021·Granted Aug 13, 2024·0 cites·14 claims
- 3469US2021277150A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 3568US11248037B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2019·Granted Feb 15, 2022·0 cites·36 claims
- 3668US2021009659A1Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 3767US2025215115A1Modified antigen bindingpolypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 3865US2020087414A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS INC·Filed 2019·Application pending·0 cites
- 3961US2019248897A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS INC·Filed 2019·Application pending·0 cites
- 4059US2025014673A1Systems and methods for polymer side-chain conformation predictionZYMEWORKS BC INC·Filed 2022·Application pending·0 cites
- 4159US2014154253A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS INC·Filed 2013·Application pending·0 cites
- 4258US2025014683A1Systems and methods for polymer sequence predictionZYMEWORKS BC INC·Filed 2022·Application pending·0 cites
- 4358US2025019440A1Immunomodulatory trispecific t cell engager fusion proteinsZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 4458US2024294667A9Heterodimeric iga fc constructs and methods of use thereofZYMEWORKS BC INC·Filed 2021·Application pending·0 cites
- 4557US2025314662A1Novel cytokine-based therapies and methodsREVERB THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4656US2025313620A1Novel cytokine-based therapies and methodsREVERB THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4754US2023331809A1Fusion proteins comprising a ligand-receptor pair and a biologically functional proteinZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 4854US2016114057A1Modular protein drug conjugate therapeuticZYMEWORKS INC·Filed 2014·Application pending·0 cites
- 4954US2013336973A1Heteromultimer Constructs of Immunoglobulin Heavy Chains with Mutations in the Fc DomainZYMEWORKS INC·Filed 2013·Application pending·0 cites
- 5054US2015125449A1Single-Arm Monovalent Antibody Constructs and Uses ThereofZYMEWORKS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →